Skip to content
Home/Companies/Pharma/Shenghuo

Shenghuo

Pharma·China·Exited 2020·Held 6yr
Entry
2014
Hold
6yr
Exit
2020

Who owns Shenghuo?

Shenghuo is a Chinese Pharma company, now owned by China Resources Sanjiu Medical & Pharmaceutical, which acquired it in 2020 from Cathay Capital.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Cathay Capital
Investor
Cathay Capital
Cathay Capital Midcap I · 2014 · Buyout

Key facts

HQChina
SectorPharma
Exit Type
Trade Sale
Buyer
China Resources Sanjiu Medical & Pharmaceutical
Exit Year
2020

More from Cathay Capital Midcap I

Other portfolio companies in the same fund.

Powell
Active
SoftwareFrance· 2025
Jiuhetang
Active
HealthcareChina· 2018
ABS
Exited 2022
ConsumerChina· 2016
ABV
Active
ConsumerUS· 2016
ATI
Exited 2022
HealthcareFrance· 2016
ATRenew (Aihuishou)
ATRenew (Aihuishou)
Active
ConsumerChina· 2016

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Shenghuo?

Shenghuo is now owned by China Resources Sanjiu Medical & Pharmaceutical, which acquired it in 2020 from Cathay Capital.

When did China Resources Sanjiu Medical & Pharmaceutical acquire Shenghuo?

China Resources Sanjiu Medical & Pharmaceutical acquired Shenghuo in 2020, buying from Cathay Capital.

Who did Shenghuo sell to?

Cathay Capital sold Shenghuo to China Resources Sanjiu Medical & Pharmaceutical in 2020 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue